VAERS reports by lot

GSK Varicella/Shingles lot 2F9C5: VAERS reports

22 VAERS reports list lot 2F9C5 as a GSK Varicella/Shingles vaccine, received between 2024-03-07 and 2025-02-10. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
9%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)1122%
Injection-site / Local reaction1020%
Neurological816%
General / Systemic (non-local)612%
Allergic / Anaphylactic48%
Musculoskeletal48%
Gastrointestinal36%
Thrombotic / Hematological24%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas4
Minnesota2
California2
Arkansas2
Idaho1
Nevada1
South Dakota1
Michigan1
West Virginia1
Alabama1
Kentucky1
Massachusetts1

Reports by month received

MonthReportsBar
2024-038
2024-045
2024-053
2024-063
2024-072
2025-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Varicella/Shingles lots (A–Z): 2AH5M · 2B3P2 · 2BR9G · 2G2T7 · 2JA2N · 2K9T2

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.